Javascript must be enabled to continue!
Restructuring Charges, FAS 146, and the Accrual Anomaly
View through CrossRef
In this study, we examine the role of restructuring charges in the existence and subsequent weakening of the widely documented accrual anomaly. We find that prior to 2003, the significant positive abnormal hedge returns experienced by accrual based strategies were influenced by a subset of firms with high restructuring charges. After 2003, with the introduction of the Statement of Financial Accounting Standards No. 146 changing the accounting for restructuring charges, restructuring firms no longer experience significant abnormal returns, thereby weakening the accrual anomaly. Our results suggest that the regulatory changes have had an effect on impairing the role of restructuring charges in the accrual anomaly by improving the market’s ability to correctly assess the valuation implications of restructuring charges in the low accruals portfolios. This paper was accepted by Mary Barth, accounting.
Institute for Operations Research and the Management Sciences (INFORMS)
Title: Restructuring Charges, FAS 146, and the Accrual Anomaly
Description:
In this study, we examine the role of restructuring charges in the existence and subsequent weakening of the widely documented accrual anomaly.
We find that prior to 2003, the significant positive abnormal hedge returns experienced by accrual based strategies were influenced by a subset of firms with high restructuring charges.
After 2003, with the introduction of the Statement of Financial Accounting Standards No.
146 changing the accounting for restructuring charges, restructuring firms no longer experience significant abnormal returns, thereby weakening the accrual anomaly.
Our results suggest that the regulatory changes have had an effect on impairing the role of restructuring charges in the accrual anomaly by improving the market’s ability to correctly assess the valuation implications of restructuring charges in the low accruals portfolios.
This paper was accepted by Mary Barth, accounting.
Related Results
Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials
Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials
Background A major challenge for randomized phase III oncology trials is the frequent low rates of patient enrollment, resulting in high rates of premature closure due to insuffici...
FAS Gene Expression Is Epigenetically Regulated and Predicts the Responsiveness to Azacitidine In High-Risk Myelodysplastic Syndromes
FAS Gene Expression Is Epigenetically Regulated and Predicts the Responsiveness to Azacitidine In High-Risk Myelodysplastic Syndromes
Abstract
Abstract 232
Background:
Low risk myelodysplastic syndromes (MDS) CD34-positive cells exhibit high level...
Mutation of CD95 (Fas/Apo-1) Gene in Adult T-Cell Leukemia Cells
Mutation of CD95 (Fas/Apo-1) Gene in Adult T-Cell Leukemia Cells
AbstractCD95 antigen (also known as Fas or Apo-1) and Fas ligand play key roles in apoptosis of cells of the immune system, function as effector molecules of cytotoxic T lymphocyte...
Mutation of CD95 (Fas/Apo-1) Gene in Adult T-Cell Leukemia Cells
Mutation of CD95 (Fas/Apo-1) Gene in Adult T-Cell Leukemia Cells
CD95 antigen (also known as Fas or Apo-1) and Fas ligand play key roles in apoptosis of cells of the immune system, function as effector molecules of cytotoxic T lymphocytes, and f...
Distinct Molecular Mechanisms of Fas Resistance in Murine B Lymphoma Cells
Distinct Molecular Mechanisms of Fas Resistance in Murine B Lymphoma Cells
Abstract
A panel of murine B lymphoma cell lines, which express different levels of Fas, was extensively studied for sensitivity to Fas-mediated death signals via an...
High Endothelial Venules of the Lymph Nodes Express Fas Ligand
High Endothelial Venules of the Lymph Nodes Express Fas Ligand
Fas (CD95, APO-1) is widely expressed on lymphatic cells, and by interacting with its natural ligand (Fas-L), Fas induces apoptosis through a complex caspase cascade. In this study...
Inside the 'Accrual Anomaly'
Inside the 'Accrual Anomaly'
Sloan (1996) and a number of subsequent studies present evidence that a trading strategy based on publicly available accounting accruals earns abnormal returns of approximately 10%...
AKRUAL: PROKSI EARNINGS QUALITY YANG MASIH DIPERDEBATKAN
AKRUAL: PROKSI EARNINGS QUALITY YANG MASIH DIPERDEBATKAN
The study tried to confirm the statement of the presence of the anomaly in the accrual component persistence as proxied the earnings quality. Previous study by Sloan (1996) found t...

